BBNX vs WY · rev $100.3M vs P/E 43, rev $3.59B
Beta Bionics, Inc. Common Stock (BBNX) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
BBNX currently screens at market cap $640.8M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the BBNX and WY stock pages for the full models.
Not investment advice.